Policy & Regulation
8 August 2022 - Innovent Biologics Inc (HKEX: 01801), a China-based biopharmaceutical company, announced on Sunday that it has dosed its first patient with diabetic macular edema (DME) in the phase on...
8 August 2022 - Kodiak Sciences Inc. (Nasdaq: KOD), a US-based biopharmaceutical company, announced on Friday that it has completed enrolment in its GLOW Phase three clinical trial of tarcocimab tedro...
8 August 2022 - United States-based contract research organisation Vial announced on Sunday that it has named Dr Neeraj Agarwal as scientific advisor for the company's Oncology CRO.Dr Agarwal is ...
8 August 2022 - Innovent Biologics Inc (HKEX: 01801), a China-based biopharmaceutical company, announced on Sunday that it has dosed its first patient with diabetic macular edema (DME) in the phase on...
8 August 2022 - Transcenta Holding Limited (HKEX: 06628), a China-based, clinical stage biopharmaceutical company, announced on Sunday that it has named Dr Caroline Germa as its executive vice preside...
8 August 2022 - China-based Ascletis Pharma Inc. (HKEX: 1672) announced on Sunday that it has completed dosing its first patient in the United States phase one clinical trial of ASC61, an oral PD-L1 s...
Related Headlines